DE69201058T2 - Perhydroisoindol derivate und ihre herstellung. - Google Patents

Perhydroisoindol derivate und ihre herstellung.

Info

Publication number
DE69201058T2
DE69201058T2 DE69201058T DE69201058T DE69201058T2 DE 69201058 T2 DE69201058 T2 DE 69201058T2 DE 69201058 T DE69201058 T DE 69201058T DE 69201058 T DE69201058 T DE 69201058T DE 69201058 T2 DE69201058 T2 DE 69201058T2
Authority
DE
Germany
Prior art keywords
radical
general formula
radicals
atom
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69201058T
Other languages
German (de)
English (en)
Other versions
DE69201058D1 (de
Inventor
Daniel Achard
Serge Grisoni
Stephen Hanessian
Claude Moutonnier
Jean-Francois Peyronel
Michel Tabart
Alain Truchon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of DE69201058D1 publication Critical patent/DE69201058D1/de
Publication of DE69201058T2 publication Critical patent/DE69201058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69201058T 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung. Expired - Fee Related DE69201058T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9106036A FR2676443B1 (fr) 1991-05-17 1991-05-17 Nouveaux derives de perhydroisoindole et leur preparation.
PCT/FR1992/000430 WO1992020654A1 (fr) 1991-05-17 1992-05-15 Nouveaux derives de perhydroisoindole et leur preparation

Publications (2)

Publication Number Publication Date
DE69201058D1 DE69201058D1 (de) 1995-02-09
DE69201058T2 true DE69201058T2 (de) 1995-05-11

Family

ID=9412908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69201058T Expired - Fee Related DE69201058T2 (de) 1991-05-17 1992-05-15 Perhydroisoindol derivate und ihre herstellung.

Country Status (23)

Country Link
US (1) US5508433A (en:Method)
EP (2) EP0586471B1 (en:Method)
JP (1) JPH06507628A (en:Method)
AT (1) ATE116295T1 (en:Method)
AU (1) AU1884092A (en:Method)
CA (1) CA2109297A1 (en:Method)
CZ (1) CZ244893A3 (en:Method)
DE (1) DE69201058T2 (en:Method)
DK (1) DK0586471T3 (en:Method)
ES (1) ES2066620T3 (en:Method)
FI (1) FI935072A0 (en:Method)
FR (1) FR2676443B1 (en:Method)
HU (1) HUT68913A (en:Method)
IE (1) IE921579A1 (en:Method)
IL (1) IL101867A0 (en:Method)
MX (1) MX9202288A (en:Method)
NO (1) NO933976D0 (en:Method)
NZ (1) NZ242773A (en:Method)
SK (1) SK126893A3 (en:Method)
TW (1) TW226991B (en:Method)
WO (1) WO1992020654A1 (en:Method)
YU (1) YU51692A (en:Method)
ZA (1) ZA923541B (en:Method)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2689889B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, et leur preparation.
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
FR2703679B1 (fr) * 1993-04-05 1995-06-23 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2710913B1 (fr) * 1993-10-07 1995-11-24 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2709752B1 (fr) * 1993-07-30 1995-10-06 Rhone Poulenc Rorer Sa Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
TW365603B (en) * 1993-07-30 1999-08-01 Rhone Poulenc Rorer Sa Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
US7163949B1 (en) 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
CN1414953A (zh) 1999-11-03 2003-04-30 阿尔巴尼分子研究公司 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和5－羟色胺重摄取的用途
BR0112350A (pt) 2000-07-11 2003-06-24 Albany Molecular Res Inc Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico
US6709651B2 (en) 2001-07-03 2004-03-23 B.M.R.A. Corporation B.V. Treatment of substance P-related disorders
CA2573271C (en) 2004-07-15 2015-10-06 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ATE550019T1 (de) 2005-05-17 2012-04-15 Merck Sharp & Dohme Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
NZ565111A (en) 2005-07-15 2011-10-28 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AU2008204380B2 (en) 2007-01-10 2013-08-15 Msd Italia S.R.L. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
CA2690191C (en) 2007-06-27 2015-07-28 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
EP2413932A4 (en) 2009-04-01 2012-09-19 Merck Sharp & Dohme HAMMER OF ACT ACTIVITY
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.
JP5764553B2 (ja) 2009-05-12 2015-08-19 アルバニー モレキュラー リサーチ， インコーポレイテッド ７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンおよびその使用
MX2011011900A (es) 2009-05-12 2012-01-20 Squibb Bristol Myers Co Formas cristalinas de (s)-7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4 -(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y usos de las misma.
AU2010307198B9 (en) 2009-10-14 2014-02-13 Merck Sharp & Dohme Corp. Substituted piperidines that increase p53 activity and the uses thereof
CN107090456B (zh) 2010-08-02 2022-01-18 瑟纳治疗公司 使用短干扰核酸的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1基因表达的抑制
SI2606134T1 (sl) 2010-08-17 2019-08-30 Sirna Therapeutics, Inc. RNA-INTERFERENČNO POSREDOVANO ZAVIRANJE IZRAŽANJA GENA VIRUSA HEPATITISA B (HBV) Z UPORABO KRATKE INTERFERENČNE NUKLEINSKE KISLINE (siNA)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
WO2012036997A1 (en) 2010-09-16 2012-03-22 Schering Corporation Fused pyrazole derivatives as novel erk inhibitors
EP3327125B1 (en) 2010-10-29 2020-08-05 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
US20140045832A1 (en) 2011-04-21 2014-02-13 Piramal Enterprises Limited Insulin-Like Growth Factor-1 Receptor Inhibitors
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
EP3358013B1 (en) 2012-05-02 2020-06-24 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
US9233979B2 (en) 2012-09-28 2016-01-12 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
PL2925888T3 (pl) 2012-11-28 2018-03-30 Merck Sharp & Dohme Corp. Kompozycje i sposoby do stosowania w leczeniu nowotworów
KR102196882B1 (ko) 2012-12-20 2020-12-30 머크 샤프 앤드 돔 코포레이션 Hdm2 억제제로서의 치환된 이미다조피리딘
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
US10975084B2 (en) 2016-10-12 2021-04-13 Merck Sharp & Dohme Corp. KDM5 inhibitors
US11098059B2 (en) 2017-11-08 2021-08-24 Merck Sharp & Dohme Corp. PRMT5 inhibitors
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
US11981701B2 (en) 2018-08-07 2024-05-14 Merck Sharp & Dohme Llc PRMT5 inhibitors
EP3833668B1 (en) 2018-08-07 2025-03-19 Merck Sharp & Dohme LLC Prmt5 inhibitors
WO2020033288A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
AU502760B2 (en) * 1977-02-28 1979-08-09 Science Union Et Cie, Societe Francaise De Recherche Medicale Azabicycloalkanes and their preparation
EP0058567B1 (en) * 1981-02-17 1984-07-25 Warner-Lambert Company Substituted acyl derivatives of octahydro-1h-isoindole-1-carboxylic acids and esters
US4439229A (en) * 1981-06-29 1984-03-27 Rohm And Haas Company Substituted phthalimides herbicides
JPH0278659A (ja) * 1988-09-12 1990-03-19 Shionogi & Co Ltd アザビシクロアルカン類化合物
FR2654725B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ES2066620T3 (es) 1995-03-01
HUT68913A (en) 1995-08-28
ZA923541B (en) 1993-01-27
TW226991B (en:Method) 1994-07-21
EP0586471A1 (fr) 1994-03-16
ATE116295T1 (de) 1995-01-15
AU1884092A (en) 1992-12-30
FR2676443B1 (fr) 1993-08-06
FI935072A7 (fi) 1993-11-16
IL101867A0 (en) 1992-12-30
US5508433A (en) 1996-04-16
HU9303250D0 (en) 1994-03-28
DK0586471T3 (da) 1995-06-06
DE69201058D1 (de) 1995-02-09
FI935072L (fi) 1993-11-16
NO933976L (no) 1993-11-03
EP0514274A1 (fr) 1992-11-19
IE921579A1 (en) 1992-11-18
NZ242773A (en) 1994-06-27
FI935072A0 (fi) 1993-11-16
EP0586471B1 (fr) 1994-12-28
SK126893A3 (en) 1994-11-09
YU51692A (sh) 1994-06-10
CA2109297A1 (fr) 1992-11-18
NO933976D0 (no) 1993-11-03
CZ244893A3 (en) 1994-04-13
JPH06507628A (ja) 1994-09-01
FR2676443A1 (fr) 1992-11-20
MX9202288A (es) 1992-11-01
WO1992020654A1 (fr) 1992-11-26

Similar Documents

Publication Publication Date Title
DE69201058T2 (de) Perhydroisoindol derivate und ihre herstellung.
DE69209290T2 (de) Perhydroisoindolderivate, ihre herstellung und diese enthaltende arzneimittel
DE69010851T2 (de) Isoindolonderivate, ihre Herstellung und ihre Verwendung als Zwischenprodukte zur Herstellung von Substanz-P-Antagonisten.
DE69319235T2 (de) Perhydroisoindole derivate als substanz p antagonisten
DE69413542T2 (de) Perhydroisoindolderivate als substanz p antagonisten
DE69007429T2 (de) Isoindolonderivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
EP0397060B1 (de) Maleinimid-Derivate und deren Verwendung als Arzneimittel
DE3444572C2 (de) Indolderivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung
DE3700408A1 (de) Indolderivate, sie enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DE69108461T2 (de) 1-Indolylalkyl-4-(alkoxy-pyrimidinyl)piperazine.
DE68905365T2 (de) Benzodiazepine, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre therapeutische Verwendung.
DE69331988T2 (de) Indol derivate als 5-ht1 agoniste
DE3131728A1 (de) Indolverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69119933T2 (de) Hexahydro[cd]indole
DE69621877T2 (de) 4-Indolylpiperazinyl-Derivate
DE69319902T2 (de) Neue perhydroisoindolderivate und ihre herstellung
CH630383A5 (de) Verfahren zur herstellung von cyclischen derivaten von 1,4-benzoxazin und 1,4-benzothiazin.
DE2737630C2 (en:Method)
DE3719699A1 (de) Indolderivate
DE69526595T2 (de) Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon
DE1720033A1 (de) Neue Indolderivate und Verfahren zu ihrer Herstellung
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE68910593T2 (de) Chinolinoncarbonsäuren.
EP0271099A2 (de) Substituierte Aminopropionsäureamide, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden neuen Zwischenprodukte
EP0025501B1 (de) Neue N-Aminoalkylindol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee